Results

Total Results: 1,653 records

Showing results for "described".

241. Santa_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
     February 01, 2013 - . • People  tend  to  choose positively  described  options  when  they  perceive   … options  as  safe,  and  people  tend  to  choose negatively  described  options

242. Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
     February 18, 2023 - with Key Informants will include which long COVID models of care are in use (including models not described … The searches will be restricted to 2021 or later, corresponding to when long COVID was first described … Grey literature studies will be assessed for eligibility using the same approach as described in the … With AHRQ’s assistance, we will also attempt to identify and describe federal efforts to study or described

243. Single-arm studies in comparative effectiveness reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
     January 01, 2013 - single group studies to resolve clinical questions that are inherently comparative in nature should be described … A number of study types would be included in this category, including investigations described as ― … harms 0 (0) Quantitatively combined single group studies with comparative studies for harms 0 (0) Described … of the effects from single group studies adjacent to the 5 (24) syntheses of comparative studies Described … Only about half of these CERs (9/19, 47%) described these harms data in the context of data from comparative

244. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
     January 01, 2022 - Program Methods Guide (https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview), as described … Results The included RCTs are described in Table B. … Eight observational studies were also included and are described in Table C.

245. Disposition of Comments_Technical Brief No. 43: Measuring Healthcare Organization Characteristics in Cancer Care Delivery Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
     June 20, 2023 - Also described utility of one specific theory 25 Peer Reviewer #1 Guiding Questions The guiding … We appreciate the comment. 30 Peer Reviewer #1 Methods Authors clearly and concisely described the … discussing Key Informant engagement, the authors specified the number and type of informants, as well as described … organization, financing, and delivery of health care in the US. 35 Peer Reviewer #4 Methods Well described … with Key Informants: Not sure you need the first sentence since it is a method, and has already been described

246. Ankyloglossia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
     May 01, 2015 - Laser frenotomy or frenulotomy has also been described, and proponents argue that its use is more exact … for Healthcare Research and Quality standard of “good,” “fair,” and “poor” quality designations, as described … Bleeding was typically described as minor and limited. Reoperation was noted in seven studies. … Few studies described the specific methods they used to collect harms data. … assessment of breastfeeding difficulty and diagnostic criteria for ankyloglossia were not universally described

247. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
     March 11, 2010 - The different types of core-needle biopsy are described later; the … Introduction DCIS classifications use histologic grade, so the statement that only invasive tumors are described … Section Comment Response Introduction The process that breast biopsy works within needs to be better described … The searches for literature addressing all questions are exactly as described. … supplemented with expert opinion (e.g., the Technical Expert Panel and review articles identified by the described

248. Smoking-Pregnancy-Infants Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
     February 01, 2014 - adjustment of the data and results • Studies targeting women who smoke and meet the population criteria described … Data Synthesis To synthesize the data, we first divided the studies into broad categories and described … Data for Key Questions 2, 3, and 5 were described qualitatively. … effectiveness of intervention components using the meta-analysis (Table E) and using the approach described … As described earlier, incentives had the highest independent effect, but given that the statistical

249. Dementia-Agitation-Aggression Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
     November 13, 2014 - Agitation is often described as “excessive motor activity with a feeling of inner tension and characterized … such as pacing, wandering, aggression, shouting and nighttime disturbance.”16 Aggression is commonly described … the review based on the PICOTS framework outlined above and the study-specific inclusion criteria described … processes, narrow eligibility criteria, and patient and intervention characteristics different than those described … dementia.42 These applicability issues are present in the synthesis frameworks and sensitivity analyses described

250. Web Interactive Presentation of EPC Reports: A Foray Into Interactive Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
     September 01, 2019 - Conclusions: In sum, we described a foray into an alternative view of a systematic review that complements … In sum, we described a foray into an alternative view of a systematic review that complements a static

251. Liver-Cancer-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
     November 28, 2012 - o Were inclusion/exclusion criteria clearly described? … o Were baseline prognostic characteristics clearly described and groups shown to be comparable? … characteristics proposed by Carey and Boden,46 as follows: o Clearly defined question o Well-described … study population o Well-described intervention o Use of validated outcome measures o Appropriate … statistical analyses o Well-described results o Discussion and conclusion supported by data o

252. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - Peer Reviewer #1 Methods In general, methods described and used in this report are typical for systematic … This is mentioned in the text and described in detail in the appendices for each study. … We described AUR as it was described in the original trial. … TEP Reviewer #3 Discussion/ Conclusion The discussion is satisfactory, Limitations are well-described … This is described in the appendix overview table for that section.

253. Systematic Review Update: Noninvasive Nonpharmacologic Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
     December 11, 2018 - evidence to address gaps in evidence identified in the previous report and thus some of the needs described … exclusion of studies for the systematic review will be based on the Key Questions and are briefly described … The strength of the evidence may be downgraded based on the limitations described above. … effect, presence of dose-response relationship or existence of plausible unmeasured confounders) as described … review of the public comments, and input from Key Informants and the Technical Expert Panel (TEP) as described

254. Alcohol-Misuse Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
     April 28, 2010 - with a primary care-type relationship that may be applicable to traditional primary care settings as described … The steps that we will take to accomplish the literature review are described below. … Rather, since our review has some differences in scope (described above on page 5), we will search … Appropriateness will be determined by the same methods described above. Table 2. … As described above, all results will be tracked in an EndNote database.

255. Evidence-based Practice Center Systematic Review Protocol: Management of High-Need, High-Cost Patients: A Realist and Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
     November 07, 2019 - Care coordination is a central component, particularly during health care setting transitions (as described … Within that population, we will present the patterns of persistent health care use and costs described … exclusion table (continued) PICOTS Inclusion Exclusion Outcomes KQ 1: Population characteristics described … We will identify all eligible studies using the same criteria described above. … As described above, all results will be tracked in an EndNote database. 14 For the realist

256. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
     January 01, 2014 - The objective is described in the Scope section of the Executive Summary. … The methods for inclusion are clearly described. Thank you. … I would suggest that the differences just be described and avoid value terms when possible. … The one study is not described as RCT or observational as is done in all the other sections. … The explanation and how it was handled was well-described for the reader and seemed appropriate.

257. Healthcare Delivery of Clinical Preventive Services for People with Disabilities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-protocol.pdf
     January 16, 2024 - criteria for inclusion and exclusion of individual studies are based on the Key Questions and PICOTS described … the ICF.39,40 We will construct evidence tables with the relevant data from included studies (as described … Questions, we will conduct additional sub-group analyses of specific populations of interest (as described … We will use the approach described in the AHRQ Methods Guide.49 To ensure reliability and validity of … Applicability of Evidence We will assess applicability according to the approach described in the AHRQ

258. breast-cancer-imaging-protocol-131217 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
     December 17, 2013 - of the research team (LG, CL) for inclusion or exclusion on the basis of the eligibility criteria described … Race (Percentages) Other cancer characteristics Intervention characteristics Type(s) of imaging described

259. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
     March 01, 2012 - Strains that produce toxin A and toxin B and strains that produce only toxin B have been described. … Strains that produce only toxin A have not been described, but this is not clear from the current wording … The described program is still ongoing with the outcome sustained. See response below. … Also the risk rates described as very small, moderate and substantial are not well defined or supported … In the study by Surawicz (Clin Infect Dis 2001), the sample is described as patients with recurrent

260. Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
     March 29, 2016 - Commentator & Affiliation Section Comment Response Peer Reviewer #3 Methods The methods described … The search strategy listed is logical and clearly described. … The characteristics of the studies are clearly described. … Similarly, rifaximin is described and used as an adjunct therapy (albeit one that is an antibiotic) … Limitations of the review/studies are clearly & adequately described.